UiPath Inc. (NYSE:PATH) CFO Ashim Gupta Sells 40,000 Shares of Stock

UiPath Inc. (NYSE:PATH) CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $19.79, for a total value of $791,600.00. Following the completion of the sale, the chief financial officer now owns 946,848 shares of the company’s stock, valued at approximately $18,738,121.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Ashim Gupta also recently made the following trade(s):

• On Thursday, April 4th, Ashim Gupta sold 40,000 shares of UiPath stock. The shares were sold at an average price of $21.66, for a total value of $866,400.00.
• On Friday, March 15th, Ashim Gupta sold 16,000 shares of UiPath stock. The shares were sold at an average price of $22.84, for a total value of $365,440.00.

UiPath Stock Performance

Shares of NYSE:PATH opened at $19.89 on Thursday. The firm has a market cap of $11.32 billion, a PE ratio of -117.00 and a beta of 1.01. UiPath Inc. has a 52 week low of $13.30 and a 52 week high of $27.87. The firm’s fifty day moving average is $21.53 and its 200-day moving average is $21.77.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The company had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. Sell-side analysts forecast that UiPath Inc. will post -0.04 EPS for the current year.

Institutional Investors Weigh In On UiPath

A number of institutional investors have recently modified their holdings of PATH. Mark Sheptoff Financial Planning LLC bought a new stake in UiPath during the fourth quarter valued at $25,000. HighMark Wealth Management LLC bought a new stake in UiPath in the fourth quarter worth approximately $27,000. ORG Partners LLC lifted its stake in UiPath by 875.6% in the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after buying an additional 1,112 shares during the period. Cypress Capital Management LLC WY bought a new position in shares of UiPath during the 4th quarter worth approximately $29,000. Finally, Fifth Third Bancorp increased its stake in shares of UiPath by 2,005.3% in the 3rd quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock valued at $34,000 after acquiring an additional 1,905 shares in the last quarter. 62.50% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on PATH shares. Wells Fargo & Company lifted their price target on UiPath from $24.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, March 14th. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 price target on shares of UiPath in a report on Wednesday, March 20th. Canaccord Genuity Group increased their price objective on shares of UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, March 15th. TD Cowen increased their price target on shares of UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday, March 14th. Finally, Truist Financial restated a “buy” rating and set a $32.00 price objective on shares of UiPath in a report on Wednesday, March 20th. Nine equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $27.41.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.